| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6055523 | Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology | 2015 | 7 Pages |
Abstract
HBOT may have utility for treating radiation-induced xerostomia refractory to other therapies. Additionally, HBOT may induce long-term improvement in subjective assessments of xerostomia, whereas other therapies currently available only provide short-term relief. The strength of these conclusions is limited by the lack of randomized controlled clinical trials.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Nyssa F. MD, Christopher BA, Amit J. MD, Tiffany L. DMD, Shaun A. MD, MA, Anand MBBS, DLO, Terry A. MD,